Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Wolfman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Sexual Medicine Reviews|September 22, 2025
Genitourinary syndrome of menopause (GSM): recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)James A Simon, Rossella E Nappi, Peter Chedraui, et al.
Maturitas|November 19, 2025
Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysisMarla Shapiro C M, Genevieve Neal-Perry, Petra Stute, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|September 16, 2014
Managing menopauseRobert Reid, Beth L Abramson, Jennifer Blake, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 2, 2019
N° 311 - Prise en charge de la ménopause (Résumé/Déclarations Sommaires et Recommandations)Robert Reid, Beth L Abramson, Jennifer Blake, et al.
Obstetrics and Gynecology|March 10, 2023
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled TrialGenevieve Neal-Perry, Antonio Cano, Samuel Lederman, et al.
Menopause (New York, N.Y.)|August 16, 2020
Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriersJavier Mejia-Gomez, Jacek Gronwald, Leigha Senter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 19, 2011
SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010Robert Reid, Nicholas Leyland, Wendy Wolfman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2023
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCTKimball A Johnson, Nancy Martin, Rossella E Nappi, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 8, 2017
First International Consensus Report on Adnexal Masses: Management RecommendationsPhyllis Glanc, Beryl Benacerraf, Tom Bourne, et al.
Anaerobe|May 8, 2022
First reported case of Robinsoniella peoriensis pyometra and bloodstream infection: A case report and review of the literatureJavier Mejia-Gomez, Tiffany Zigras, Yashesh Patel, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Sexual Medicine Reviews|September 22, 2025
Genitourinary syndrome of menopause (GSM): recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)James A Simon, Rossella E Nappi, Peter Chedraui, et al.
Maturitas|November 19, 2025
Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysisMarla Shapiro C M, Genevieve Neal-Perry, Petra Stute, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|September 16, 2014
Managing menopauseRobert Reid, Beth L Abramson, Jennifer Blake, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 2, 2019
N° 311 - Prise en charge de la ménopause (Résumé/Déclarations Sommaires et Recommandations)Robert Reid, Beth L Abramson, Jennifer Blake, et al.
Obstetrics and Gynecology|March 10, 2023
Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled TrialGenevieve Neal-Perry, Antonio Cano, Samuel Lederman, et al.
Menopause (New York, N.Y.)|August 16, 2020
Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriersJavier Mejia-Gomez, Jacek Gronwald, Leigha Senter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 19, 2011
SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010Robert Reid, Nicholas Leyland, Wendy Wolfman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2023
Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCTKimball A Johnson, Nancy Martin, Rossella E Nappi, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|March 8, 2017
First International Consensus Report on Adnexal Masses: Management RecommendationsPhyllis Glanc, Beryl Benacerraf, Tom Bourne, et al.
Anaerobe|May 8, 2022
First reported case of Robinsoniella peoriensis pyometra and bloodstream infection: A case report and review of the literatureJavier Mejia-Gomez, Tiffany Zigras, Yashesh Patel, et al.
Pageof 6